BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

940 related articles for article (PubMed ID: 18845171)

  • 1. Are dopaminergic pathways involved in theory of mind? A study in Parkinson's disease.
    Péron J; Vicente S; Leray E; Drapier S; Drapier D; Cohen R; Biseul I; Rouaud T; Le Jeune F; Sauleau P; Vérin M
    Neuropsychologia; 2009 Jan; 47(2):406-14. PubMed ID: 18845171
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Theory of Mind in Parkinson's disease.
    Poletti M; Enrici I; Bonuccelli U; Adenzato M
    Behav Brain Res; 2011 Jun; 219(2):342-50. PubMed ID: 21238496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Affective and cognitive Theory of Mind in patients with parkinson's disease.
    Bodden ME; Mollenhauer B; Trenkwalder C; Cabanel N; Eggert KM; Unger MM; Oertel WH; Kessler J; Dodel R; Kalbe E
    Parkinsonism Relat Disord; 2010 Aug; 16(7):466-70. PubMed ID: 20538499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is "reading mind in the eyes" impaired in Parkinson's disease?
    Tsuruya N; Kobayakawa M; Kawamura M
    Parkinsonism Relat Disord; 2011 May; 17(4):246-8. PubMed ID: 20889365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dopamine asymmetry interacts with medication to affect cognition in Parkinson's disease.
    Tomer R; Aharon-Peretz J; Tsitrinbaum Z
    Neuropsychologia; 2007 Jan; 45(2):357-67. PubMed ID: 16876208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Affective theory of mind in patients with Parkinson's disease.
    Poletti M; Vergallo A; Ulivi M; Sonnoli A; Bonuccelli U
    Psychiatry Clin Neurosci; 2013 May; 67(4):273-6. PubMed ID: 23683159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Motor procedural learning in Parkinson's disease.
    Muslimovic D; Post B; Speelman JD; Schmand B
    Brain; 2007 Nov; 130(Pt 11):2887-97. PubMed ID: 17855374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroanatomical correlates of impaired decision-making and facial emotion recognition in early Parkinson's disease.
    Ibarretxe-Bilbao N; Junque C; Tolosa E; Marti MJ; Valldeoriola F; Bargallo N; Zarei M
    Eur J Neurosci; 2009 Sep; 30(6):1162-71. PubMed ID: 19735293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advanced Theory of Mind in patients at early stage of Parkinson's disease.
    Yu RL; Wu RM; Chiu MJ; Tai CH; Lin CH; Hua MS
    Parkinsonism Relat Disord; 2012 Jan; 18(1):21-4. PubMed ID: 21868278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The recognition of facial emotion expressions in Parkinson's disease.
    Assogna F; Pontieri FE; Caltagirone C; Spalletta G
    Eur Neuropsychopharmacol; 2008 Nov; 18(11):835-48. PubMed ID: 18707851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recognition of emotional prosody is altered after subthalamic nucleus deep brain stimulation in Parkinson's disease.
    Péron J; Grandjean D; Le Jeune F; Sauleau P; Haegelen C; Drapier D; Rouaud T; Drapier S; Vérin M
    Neuropsychologia; 2010 Mar; 48(4):1053-62. PubMed ID: 20005239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emotion and object processing in Parkinson's disease.
    Cohen H; Gagné MH; Hess U; Pourcher E
    Brain Cogn; 2010 Apr; 72(3):457-63. PubMed ID: 20167412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of acute tryptophan depletion on cognition, memory and motor performance in Parkinson's disease.
    Scholtissen B; Verhey FR; Adam JJ; Prickaerts J; Leentjens AF
    J Neurol Sci; 2006 Oct; 248(1-2):259-65. PubMed ID: 16756999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Don't look now or look away: two sources of saccadic disinhibition in Parkinson's disease?
    van Stockum S; MacAskill M; Anderson T; Dalrymple-Alford J
    Neuropsychologia; 2008 Nov; 46(13):3108-15. PubMed ID: 18674551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of Parkinson's disease and dopaminergic medication on proprioceptive processing.
    Mongeon D; Blanchet P; Messier J
    Neuroscience; 2009 Jan; 158(2):426-40. PubMed ID: 18996173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intensity-dependent facial emotion recognition and cognitive functions in Parkinson's disease.
    Assogna F; Pontieri FE; Cravello L; Peppe A; Pierantozzi M; Stefani A; Stanzione P; Pellicano C; Caltagirone C; Spalletta G
    J Int Neuropsychol Soc; 2010 Sep; 16(5):867-76. PubMed ID: 20663240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuropsychological correlates of theory of mind in patients with early Parkinson's disease.
    Santangelo G; Vitale C; Trojano L; Errico D; Amboni M; Barbarulo AM; Grossi D; Barone P
    Mov Disord; 2012 Jan; 27(1):98-105. PubMed ID: 21915910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emotion recognition impairment in Parkinson's disease patients without dementia.
    Herrera E; Cuetos F; Rodríguez-Ferreiro J
    J Neurol Sci; 2011 Nov; 310(1-2):237-40. PubMed ID: 21752398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dissociable prefrontal networks for cognitive and affective theory of mind: a lesion study.
    Shamay-Tsoory SG; Aharon-Peretz J
    Neuropsychologia; 2007 Oct; 45(13):3054-67. PubMed ID: 17640690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A functional MRI study of Theory of Mind in euthymic bipolar disorder patients.
    Malhi GS; Lagopoulos J; Das P; Moss K; Berk M; Coulston CM
    Bipolar Disord; 2008 Dec; 10(8):943-56. PubMed ID: 19594509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 47.